Modernizing Surrogate Decision-Making to Reflect the Complexity of Cancer Care

AI Summary

This viewpoint proposes a modernized framework for surrogate decision-making in cancer care that emphasizes patient process preferences and adaptability to evolving therapies. The piece presents expert normative guidance rather than empirical evidence of outcomes or effectiveness.

Plain-language summary

This is a viewpoint piece proposing a framework for surrogate decision-making in cancer care; it presents expert perspective and normative guidance rather than empirical evidence of efficacy or outcomes.

Clinical bottom line

This guidance suggests clinicians and surrogate decision-makers should adopt a more flexible, process-oriented approach to decision-making that respects evolving cancer therapies and patient values, but the piece does not provide empirical evidence that this approach improves outcomes.

Caveats

• No empirical data, outcome measures, or comparative evidence presented.
• No patient or clinician outcome data reported.
• No sample size or statistical analysis provided.
• Conceptual framework only; effectiveness not demonstrated.

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.